| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $3.5M | +1722.4% |
| SG&A Expense | $7.7M | +68.7% |
| Operating Income | -$11.2M | -136.4% |
| Income Tax | $0 | — |
| Net Income | -$11.2M | -109.9% |
| EPS (Basic) | -$1.16 | +24.2% |
| EPS (Diluted) | -$1.16 | +24.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.2M | +142.2% |
| Current Assets | $5.4M | +184.1% |
| Total Assets | $5.6M | +198.3% |
| Current Liabilities | $2.3M | +195.1% |
| Total Liabilities | $2.5M | +221.4% |
| Stockholders' Equity | $3.1M | +182.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$10.2M | -146.4% |
| Financing Cash Flow | $12.7M | +126.2% |